In addition to a high POU2F1 expression level, a tumor ≥ 5 cm, clinical stage III-IV, the presence of PVTT and HCC metastasis were also associated with shorter OS and higher death rates (Figure 2, Figure 3A, Figure 3B and Table 2). This evidence concerns the gene POU2F1 and neoplasm.